Globus Medical Operating Margin 2010-2022 | GMED
Current and historical operating margin for Globus Medical (GMED) over the last 10 years. The current operating profit margin for Globus Medical as of September 30, 2022 is 20.29%.
| Globus Medical Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2022-09-30 |
$1.00B |
$0.19B |
19.22% |
| 2022-06-30 |
$0.98B |
$0.19B |
18.97% |
| 2022-03-31 |
$0.96B |
$0.16B |
16.94% |
| 2021-12-31 |
$0.96B |
$0.17B |
17.95% |
| 2021-09-30 |
$0.94B |
$0.21B |
22.64% |
| 2021-06-30 |
$0.93B |
$0.21B |
22.65% |
| 2021-03-31 |
$0.83B |
$0.14B |
16.73% |
| 2020-12-31 |
$0.79B |
$0.11B |
14.07% |
| 2020-09-30 |
$0.77B |
$0.10B |
13.28% |
| 2020-06-30 |
$0.75B |
$0.09B |
12.57% |
| 2020-03-31 |
$0.79B |
$0.16B |
20.53% |
| 2019-12-31 |
$0.79B |
$0.17B |
21.88% |
| 2019-09-30 |
$0.77B |
$0.17B |
21.43% |
| 2019-06-30 |
$0.74B |
$0.16B |
21.67% |
| 2019-03-31 |
$0.72B |
$0.16B |
22.19% |
| 2018-12-31 |
$0.71B |
$0.17B |
23.74% |
| 2018-09-30 |
$0.69B |
$0.17B |
25.14% |
| 2018-06-30 |
$0.68B |
$0.17B |
25.48% |
| 2018-03-31 |
$0.65B |
$0.17B |
25.54% |
| 2017-12-31 |
$0.64B |
$0.16B |
25.31% |
| 2017-09-30 |
$0.61B |
$0.15B |
24.35% |
| 2017-06-30 |
$0.60B |
$0.15B |
25.34% |
| 2017-03-31 |
$0.58B |
$0.15B |
26.16% |
| 2016-12-31 |
$0.56B |
$0.16B |
27.48% |
| 2016-09-30 |
$0.56B |
$0.18B |
31.53% |
| 2016-06-30 |
$0.56B |
$0.18B |
32.01% |
| 2016-03-31 |
$0.55B |
$0.18B |
32.01% |
| 2015-12-31 |
$0.55B |
$0.17B |
31.68% |
| 2015-09-30 |
$0.53B |
$0.16B |
29.51% |
| 2015-06-30 |
$0.51B |
$0.15B |
29.43% |
| 2015-03-31 |
$0.49B |
$0.15B |
29.61% |
| 2014-12-31 |
$0.48B |
$0.14B |
29.26% |
| 2014-09-30 |
$0.46B |
$0.13B |
28.42% |
| 2014-06-30 |
$0.45B |
$0.13B |
28.00% |
| 2014-03-31 |
$0.44B |
$0.11B |
23.70% |
| 2013-12-31 |
$0.43B |
$0.10B |
23.50% |
| 2013-09-30 |
$0.42B |
$0.10B |
23.57% |
| 2013-06-30 |
$0.41B |
$0.10B |
23.53% |
| 2013-03-31 |
$0.40B |
$0.12B |
29.22% |
| 2012-12-31 |
$0.39B |
$0.12B |
29.72% |
| 2012-09-30 |
$0.37B |
$0.11B |
29.41% |
| 2012-06-30 |
$0.36B |
$0.11B |
30.30% |
| 2012-03-31 |
$0.35B |
$0.10B |
29.60% |
| 2011-12-31 |
$0.33B |
$0.10B |
29.61% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Instruments Manufacturing |
$7.506B |
$0.958B |
|
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions for patients with musculoskeletal disorders. The company currently has its sales operations distributed across counties world wide. Its Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and unique surgical instruments, used in an expansive range of spinal, orthopedic and neurosurgical procedures. The spine products address the vast majority of conditions affecting the spine including degenerative conditions, deformity, tumors and trauma. Enabling Technologies are designed to enhance a surgeon's capabilities and streamline the complicated surgical procedures to be safer, less invasive, accurate and more reproducible to improve patient care and reduce radiation exposure for both patient and caregiver. The technology contains imaging, navigation and robotic assisted surgery solutions. It acquired all assets of StelKast, Inc. and Finnish engineering company Synoste Oy.
|
